Effect of QVA149 (Indacaterol Maleate/Glycopyrronium Bromide) on Cardiac Function in COPD Patients

NCT02442206 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease, COPD

Interventions

DRUG: QVA149
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals